Titre:
  • The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.
Auteur:Krayem, Mohammad; Sabbah, Malak; Najem, Ahmad; Wouters, An; Lardon, Filip; Simon, Stéphane; Sales, François; Journé, Fabrice; Awada, Ahmad; Ghanem, Ghanem Elias; Van Gestel, Dirk
Informations sur la publication:Cancers (Basel), 11, 8
Statut de publication:Publié, 2019-08
Sujet CREF:Sciences bio-médicales et agricoles
Cancérologie
Mots-clés:V600EBRAF inhibition
intrinsic and acquired resistance
melanoma
p53 activation
radiotherapy
Langue:Anglais
Identificateurs:urn:issn:2072-6694
info:doi/10.3390/cancers11081093
info:pii/cancers11081093
info:pmid/31374895